查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1423583

到 2030 年临床决策支援系统市场预测：按产品类型、组件、型态、应用、最终用户和地区进行的全球分析

Clinical Decision Support Systems Market Forecasts to 2030 - Global Analysis By Product Type, Component, Mode of Delivery, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球临床决策支援系统市场规模将达到 17 亿美元，预计到 2030 年将达到 32 亿美元，预测期内复合年增长率为 9.5%。

临床决策支援系统 (CDSS) 是一种基于电脑的工具或软体，旨在透过在护理点提供相关资讯和知识来协助医疗保健专业人员做出临床决策。这些系统整合了患者资料、医学知识和最佳实践，以提供建议、提醒和警报，以帮助诊断、治疗和管理患者。目标是改善医疗保健结果、提高病人安全并支持临床医生提供更明智、更有效率的照护。

根据国家卫生资讯技术协调员办公室 (ONC) 的数据，截至 2021 年，美国约 96% 的非联邦急诊医院和近五分之四 (78%) 的执业医生获得了认证。引入了电子健康记录（EHR）系统。

对优质医疗保健的需求不断增长

对提供优质医疗保健的日益关注正在增加市场需求。随着医疗保健变得越来越复杂，CDSS 正在成为帮助临床医生做出明智决策、改善患者治疗结果并减少错误的重要解决方案。市场扩张反映出医疗保健系统内对先进技术整合的需求不断增长，从而实现高效的资料分析、个人化的患者照护、简化的决策流程以及更高的医疗保健服务标准。

资料品质和可访问性

在这个市场中，人们不断强调资料的准确性、完整性和可访问性，以确保最佳的系统功能。这包括整合不同的资料来源、实施强大的检验流程以及优先考虑互通性以实现无缝资讯交流。对资料品质和可访问性的关注对于这一演变至关重要，因为它增强了医疗保健专业人员的信心，并使他们能够做出越来越明智的临床决策。这些都是限制市场成长的因素。

提高资料可用性

医疗技术、互通性标准和数位健康记录的进步正在迅速提高资料的可用性。这种涌入包含了不同的患者资料，包括基因组资讯、即时监测和全面的病历。更轻鬆地存取资料使这些系统能够提供更准确和个人化的建议，改善医疗保健结果，同时提高临床决策流程的效率和准确性。促进改进治疗策略。

成本和资源限制

发展需要对先进技术、熟练的人力资源和大量临床资料进行大量投资。实施涉及客製化成本、与现有医疗保健系统的整合以及持续维护的成本。资源限制（包括获取高品质资料和演算法开发专业知识）阻碍了 CDSS 的可扩展性和创新。平衡成本效益和最佳功能是这个市场的主要障碍。

COVID-19 的影响：

COVID-19 大流行显着加速了全球临床决策支援系统 (CDSS) 的采用和开发。对远端医疗和远距医疗保健服务的依赖增加增加了对先进 CDSS 的需求，从而推动了市场成长。这些系统可协助医疗保健专业人员管理患者资料、提高诊断准确性和优化治疗计划。此次疫情凸显了高效、资料驱动的医疗保健解决方案的重要性，从而推动了该领域的市场扩张和创新。

在预测期内，互操作系统领域预计将是最大的。

预计互操作系统领域在预测期内将是最大的。这些系统优先考虑相容性，并允许不同的医疗保健软体有效地进行通讯。互通性确保患者资讯的顺利交换并提高临床决策的准确性和效率。市场趋势集中在 CDSS 解决方案上，这些解决方案可以与各种医疗保健技术互连，以优化资料利用以实现明智的医疗干预。

药物过敏警告部分预计在预测期内复合年增长率最高

药物过敏警报部分预计在预测期内复合年增长率最高。这些系统的主要优点之一是许多人对某些药物过敏，因此提供过敏警报的能力变得越来越重要。经历药物过敏的患者数量正在增加。结果，它会对接受药物的患者产生负面影响，并使患者的病情进一步恶化。

比最大的地区

由于医疗产业对资讯科技解决方案的需求不断增加，预计北美在预测期内将占据最大的市场占有率。提供优质医疗保健的重要性日益增加，快速的技术进步也促进了该地区的市场成长。科技的快速开拓以及提供优质医疗服务的重要性日益增加也推动了该地区的市场扩张。

复合年增长率最高的地区：

由于主要政府研发支出的增加，预计亚太地区在预测期内将维持最高的复合年增长率。印度、中国、日本和澳洲等国家对医疗保健领域的投资正在增加。研究和开发技术的改进以及政府在该领域的支出和投资是提高资讯科技在医疗产业渗透率的原因。

免费客製化服务

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球临床决策支援系统市场：依产品类型

  • 知识库系统
  • 非知识型系统
  • 互操作系统
  • 其他产品类型

第六章全球临床决策支援系统市场：依组成部分

  • 软体
  • 硬体
  • 服务

第七章全球临床决策支援系统市场：依交付型态

  • 本地
  • 基于网路的
  • 云端基础

第八章全球临床决策支援系统市场：依应用分类

  • 关于药物过敏的警告
  • 药物间相互作用
  • 临床提醒
  • 临床指引
  • 药物支持
  • 其他用途

第九章全球临床决策支援系统市场：依最终使用者分类

  • 药局
  • 医院
  • 诊所
  • 诊断中心
  • 门诊手术中心
  • 其他最终用户

第十章全球临床决策支援系统市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第十一章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司简介

  • McKesson Corporation
  • Koninklijke Philips NV
  • Cerner Corporation
  • Allscripts Healthcare, LLC
  • Siemens Healthineers GmbH
  • NextGen Healthcare Inc.
  • Wolters Kluwer NV
  • Agfa-Gevaert Group
  • Athenahealth, Inc.
  • IBM Corporation
  • Change Healthcare
  • Meditech
  • Epic Systems Corporation
  • Carestream
Product Code: SMRC24817

According to Stratistics MRC, the Global Clinical Decision Support Systems Market is accounted for $1.7 billion in 2023 and is expected to reach $3.2 billion by 2030 growing at a CAGR of 9.5% during the forecast period. Clinical Decision Support Systems (CDSS) are computer-based tools or software designed to assist healthcare professionals in making clinical decisions by providing relevant information and knowledge at the point of care. These systems integrate patient data, medical knowledge, and best practices to offer recommendations, reminders, or alerts to aid in diagnosis, treatment, and management of patients. The goal is to improve healthcare outcomes, enhance patient safety, and support clinicians in delivering more informed and efficient care.

According to The Office of the National Coordinator for Health Information Technology (ONC), as of 2021, in the US approximately 96 percent of non-federal acute care hospitals and nearly 4 in 5 office-based physicians (78%) have implemented a certified Electronic Health Record (EHR) system.

Market Dynamics:

Driver:

Rising demand for quality healthcare

The market experiences escalating demand owing to a growing emphasis on superior healthcare provision. As healthcare complexities rise, CDSS emerges as a critical solution, aiding clinicians in making informed decisions, improving patient outcomes, and reducing errors. The market's expansion reflects the increasing need for advanced technology integration within healthcare systems, enabling efficient data analysis, personalized patient care, and streamlined decision-making processes, fostering a higher standard of healthcare delivery.

Restraint:

Data quality and accessibility

The market continually emphasizes enhancing data accuracy, completeness, and accessibility to ensure optimal system functionality. This involves integrating diverse data sources, implementing robust validation processes, and prioritizing interoperability for seamless information exchange. As it evolves, emphasis on data quality and accessibility remains pivotal, fostering trust among healthcare professionals and enabling informed, precise clinical decisions. These are the factors restraining the growth of the market.

Opportunity:

Increasing data availability

The market is witnessing a surge in data availability, catalyzed by advancements in health tech, interoperability standards, and digital health records. This influx encompasses diverse patient data, including genomic information, real-time monitoring, and comprehensive medical histories. Enhanced data accessibility empowers these systems to offer more precise, personalized recommendations, fostering improved healthcare outcomes and treatment strategies while promoting efficiency and accuracy in clinical decision-making processes.

Threat:

Costs and resource constraints

Development demands substantial investment in advanced technology, skilled personnel, and extensive clinical data. Implementation incurs expenses related to customization, integration with existing healthcare systems, and ongoing maintenance. Resource limitations, including access to high-quality data and expertise in algorithm development, hinder CDSS scalability and innovation. Balancing cost-effectiveness with optimal functionality poses a significant hurdle in this market.

Covid-19 Impact:

The COVID-19 pandemic significantly accelerated the adoption and development of Clinical Decision Support Systems (CDSS) globally. The increased reliance on telemedicine and remote healthcare services amplified the need for advanced CDSS, driving market growth. These systems aided healthcare professionals in managing patient data, improving diagnostic accuracy, and optimizing treatment plans. The pandemic highlighted the importance of efficient and data-driven healthcare solutions, leading to an expansion in the market and innovation in this sector.

The interoperable systems segment is expected to be the largest during the forecast period

The interoperable systems segment is expected to be the largest during the forecast period. These systems prioritize compatibility, enabling diverse healthcare software to communicate effectively. Interoperability ensures fluid exchange of patient information, enhancing accuracy and efficiency in clinical decision-making. The market trend emphasizes CDSS solutions that can interconnect with various healthcare technologies, optimizing data utilization for informed medical interventions.

The drug allergy alerts segment is expected to have the highest CAGR during the forecast period

The drug allergy alerts segment is expected to have the highest CAGR during the forecast period. One major benefit of these systems is that their ability to deliver allergy alerts is becoming more and more significant, as many people have allergies to particular medications. The number of patients experiencing medication allergies is on the rise. As a result, giving medication to a patient who has been given it may have negative effects and further damage the patient's case.

Region with largest share:

North America is projected to hold the largest market share during the forecast period due to the increasing demand for information technology solutions in the health care industry. There's an increased importance for providing quality healthcare and rapid technological advancements these factors help in providing for the growth of the market in this region. The market expansion in this area is also fueled by the quick development of technology and the growing significance of offering high-quality healthcare services.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period due to increased R&D spending by governments of key nations. There are increasing investments in the healthcare sector in various countries like India China Japan and Australia. Improved research and development techniques and the expenditure and investments by the government in this field are the reasons which are helping increasing the penetration of information technology in the medical industry.

Key players in the market

Some of the key players in Clinical Decision Support Systems market include McKesson Corporation, Koninklijke Philips N.V., Cerner Corporation, Allscripts Healthcare, LLC, Siemens Healthineers GmbH, NextGen Healthcare Inc., Wolters Kluwer N.V., Agfa-Gevaert Group, Athenahealth, Inc., IBM Corporation, Change Healthcare, Meditech, Epic Systems Corporation, and Carestream.

Key Developments:

In April 2023, Elsevier B.V. (UK) announced the launch of an upgraded version of its clinical decision support solution, ClinicalKey. This enhanced platform incorporates a comprehensive drug compendium, a cutting-edge mobile application, and seamless integration into Electronic Health Records (EHR).

In December 2022, Athenahealth (US) announced that it had released enhancements to its athenaOne EHR to facilitate immediate administration of COVID-19 vaccines. The rollout includes communications, scheduling, workflow, documentation, and reporting capabilities.

In April 2022, Change Healthcare (US) launched a new edition of InterQual 2022, the firm's flagship clinical decision support solution for delivering the latest evidence-based appropriate care.

Product Types Covered:

  • Knowledge-Based Systems
  • Non-Knowledge-Based Systems
  • Interoperable Systems
  • Other Product Types

Components Covered:

  • Software
  • Hardware
  • Services

Mode of Deliveries Covered:

  • On Premise
  • Web Based
  • Cloud Based

Applications Covered:

  • Drug Allergy Alerts
  • Drug-Drug Interactions
  • Clinical Reminders
  • Clinical Guidelines
  • Drug Dosing Support
  • Other Applications

End Users Covered:

  • Pharmacies
  • Hospitals
  • Clinics
  • Diagnostic Centers
  • Ambulatory Surgical Centres
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Clinical Decision Support Systems Market, By Product Type

  • 5.1 Introduction
  • 5.2 Knowledge-Based Systems
  • 5.3 Non-Knowledge-Based Systems
  • 5.4 Interoperable Systems
  • 5.5 Other Product Types

6 Global Clinical Decision Support Systems Market, By Component

  • 6.1 Introduction
  • 6.2 Software
  • 6.3 Hardware
  • 6.4 Services

7 Global Clinical Decision Support Systems Market, By Mode of Delivery

  • 7.1 Introduction
  • 7.2 On Premise
  • 7.3 Web Based
  • 7.4 Cloud Based

8 Global Clinical Decision Support Systems Market, By Application

  • 8.1 Introduction
  • 8.2 Drug Allergy Alerts
  • 8.3 Drug-Drug Interactions
  • 8.4 Clinical Reminders
  • 8.5 Clinical Guidelines
  • 8.6 Drug Dosing Support
  • 8.7 Other Applications

9 Global Clinical Decision Support Systems Market, By End User

  • 9.1 Introduction
  • 9.2 Pharmacies
  • 9.3 Hospitals
  • 9.4 Clinics
  • 9.5 Diagnostic Centers
  • 9.6 Ambulatory Surgical Centres
  • 9.7 Other End Users

10 Global Clinical Decision Support Systems Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 McKesson Corporation
  • 12.2 Koninklijke Philips N.V.
  • 12.3 Cerner Corporation
  • 12.4 Allscripts Healthcare, LLC
  • 12.5 Siemens Healthineers GmbH
  • 12.6 NextGen Healthcare Inc.
  • 12.7 Wolters Kluwer N.V.
  • 12.8 Agfa-Gevaert Group
  • 12.9 Athenahealth, Inc.
  • 12.10 IBM Corporation
  • 12.11 Change Healthcare
  • 12.12 Meditech
  • 12.13 Epic Systems Corporation
  • 12.14 Carestream

List of Tables

  • Table 1 Global Clinical Decision Support Systems Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Clinical Decision Support Systems Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Clinical Decision Support Systems Market Outlook, By Knowledge-Based Systems (2021-2030) ($MN)
  • Table 4 Global Clinical Decision Support Systems Market Outlook, By Non-Knowledge-Based Systems (2021-2030) ($MN)
  • Table 5 Global Clinical Decision Support Systems Market Outlook, By Interoperable Systems (2021-2030) ($MN)
  • Table 6 Global Clinical Decision Support Systems Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 7 Global Clinical Decision Support Systems Market Outlook, By Component (2021-2030) ($MN)
  • Table 8 Global Clinical Decision Support Systems Market Outlook, By Software (2021-2030) ($MN)
  • Table 9 Global Clinical Decision Support Systems Market Outlook, By Hardware (2021-2030) ($MN)
  • Table 10 Global Clinical Decision Support Systems Market Outlook, By Services (2021-2030) ($MN)
  • Table 11 Global Clinical Decision Support Systems Market Outlook, By Mode of Delivery (2021-2030) ($MN)
  • Table 12 Global Clinical Decision Support Systems Market Outlook, By On Premise (2021-2030) ($MN)
  • Table 13 Global Clinical Decision Support Systems Market Outlook, By Web Based (2021-2030) ($MN)
  • Table 14 Global Clinical Decision Support Systems Market Outlook, By Cloud Based (2021-2030) ($MN)
  • Table 15 Global Clinical Decision Support Systems Market Outlook, By Application (2021-2030) ($MN)
  • Table 16 Global Clinical Decision Support Systems Market Outlook, By Drug Allergy Alerts (2021-2030) ($MN)
  • Table 17 Global Clinical Decision Support Systems Market Outlook, By Drug-Drug Interactions (2021-2030) ($MN)
  • Table 18 Global Clinical Decision Support Systems Market Outlook, By Clinical Reminders (2021-2030) ($MN)
  • Table 19 Global Clinical Decision Support Systems Market Outlook, By Clinical Guidelines (2021-2030) ($MN)
  • Table 20 Global Clinical Decision Support Systems Market Outlook, By Drug Dosing Support (2021-2030) ($MN)
  • Table 21 Global Clinical Decision Support Systems Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 22 Global Clinical Decision Support Systems Market Outlook, By End User (2021-2030) ($MN)
  • Table 23 Global Clinical Decision Support Systems Market Outlook, By Pharmacies (2021-2030) ($MN)
  • Table 24 Global Clinical Decision Support Systems Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 25 Global Clinical Decision Support Systems Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 26 Global Clinical Decision Support Systems Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 27 Global Clinical Decision Support Systems Market Outlook, By Ambulatory Surgical Centres (2021-2030) ($MN)
  • Table 28 Global Clinical Decision Support Systems Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.